机器人子宫移位与复位术中应用吲哚菁绿
本文以视频形式展示一例23岁未产女性IIIA期直肠腺癌患者在接受放化疗前,行机器人子宫移位与复位术的步骤,并静脉注射吲哚菁绿(ICG)示踪剂,借助内镜荧光成像系统验证子宫灌注。术后随访未见子宫坏死或宫颈缺血证据。作者认为静脉注射ICG是验证子宫移位与复位过程中子宫灌注的良好且简单的方法。
要点
- 机器人子宫移位与复位术中可静脉注射ICG验证子宫灌注。
- 使用无内置荧光成像系统的机器人系统时,可经助手孔置入内镜荧光成像系统观察。
- 本例术后随访未见子宫坏死或宫颈缺血证据。
核心结论
- 作者认为静脉注射ICG是验证子宫移位与复位过程中子宫灌注的良好且简单的方法。
研究设计与样本
- 视频文章,展示1例23岁未产女性IIIA期直肠腺癌患者的机器人子宫移位与复位术步骤及ICG灌注验证。
主要发现
- 通过ICG注射可容易地显示子宫灌注。
- 子宫移位与复位过程顺利。
- 随访期间未见子宫坏死或宫颈缺血证据。
临床怎么用
- 作者认为静脉注射ICG是验证子宫移位与复位过程中子宫灌注的良好且简单的方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To demonstrate the steps of robotic uterine transposition and repositioning and the use of indocyanine green (ICG) tracers to verify uterine perfusion during robotic uterine transposition and repositioning with a fluorescence imaging system. To our knowledge, a total of 25 patients who underwent uterine transposition have been reported in the literature. However, uterine necrosis has been reported after uterine transposition. It is prudent to verify uterine perfusion during uterine transposition. DESIGN: Video article. SUBJECTS: A 23-year-old nulliparous woman with stage IIIA rectal adenocarcinoma was scheduled to receive radiotherapy and chemotherapy. The patient included in this video gave consent for publication of the video and posting of the video online, including social media, the journal website, scientific literature websites (such as PubMed, ScienceDirect, Scopus, etc.), and other applicable sites. EXPOSURE: A robotic system (da Vinci Si Surgical System; Intuitive Surgical Inc., Sunnyvale, CA) without a built-in fluorescence imaging system was used. Uterine perfusion was verified by intravenous administration of an ICG tracer and visualization of the colored uterus using an endoscopic fluoroscopic imaging system (PINPOINT; Novadaq, Mississauga, Canada) in the assistant port. MAIN OUTCOME MEASURES: Visualization of uterine perfusion after uterine transposition and repositioning. RESULTS: Uterine perfusion could be easily demonstrated via ICG injection. The uterine transposition and repositioning processes were uneventful. No evidence of uterine necrosis or cervical ischemia was observed during follow-up. CONCLUSION: Intravenous administration of ICG is a good and simple method for verifying uterine perfusion during uterine transposition and repositioning.
引用
- Hsiao SM, Kuan TC, Hsieh CH, et al. Indocyanine green application during robotic uterine transposition and repositioning. Fertil Steril. 2025. PMID: 40532947. doi:10.1016/j.fertnstert.2025.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。